POS-799 EFFECT OF DARATUMUMAB/BORTEZOMIB/CYCLOPHOSPHAMIDE/DEXAMETHASONE ON RENAL FUNCTION AND HRQOL IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH RENAL INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY
A. HAVASI,
H.J. Lachmann,
N. Leung,
S. Kumar,
A.J. Waxman,
A.D. Wechalekar,
K.S. Gries,
X. Qin,
H. Pei,
N. Tran,
B.M. Weiss,
V. Sanchorawala
Affiliations
A. HAVASI
Boston University, School of Medicine, Boston, United States
H.J. Lachmann
University College London, n/a, London, United Kingdom
N. Leung
Mayo Clinic Rochester, n/a, Rochester, United States
S. Kumar
Mayo Clinic Rochester, n/a, Rochester, United States
A.J. Waxman
Hospital of the University of Pennsylvania, n/a, Philadelphia, United States
A.D. Wechalekar
University College London, n/a, London, United Kingdom
K.S. Gries
Janssen Research & Development- LLC, n/a, Raritan, United States
X. Qin
Janssen Research & Development- LLC, n/a, Spring House, United States
H. Pei
Janssen Research & Development- LLC, n/a, Titusville, United States
N. Tran
Janssen Research & Development- LLC, n/a, Los Angeles, United States
B.M. Weiss
Janssen Research & Development- LLC, n/a, Spring House, United States
V. Sanchorawala
Boston University, School of Medicine, Boston, United States
